CG Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	45.15	257.07	8.27	88.14	53.61
Short-Term Investments	635.12	484.93	179.41	55.34	-
Cash & Short-Term Investments	680.26	742	187.67	143.48	53.61
Cash Growth	25.81%	295.37%	30.80%	167.65%	-
Other Receivables	-	0.78	0.09	0.3	0
Receivables	0.52	0.78	0.09	0.3	0
Prepaid Expenses	13.51	11.43	6.36	3.42	4.8
Total Current Assets	695.79	754.21	194.12	147.21	58.41
Property, Plant & Equipment	19.53	0.49	0.49	0.51	0.2
Long-Term Deferred Charges	-	-	4.67	-	-
Other Long-Term Assets	0.11	0.09	0.02	0.03	0.09
Total Assets	729.91	754.8	199.3	147.75	58.69
Accounts Payable	9.19	6.52	3.24	0.99	1
Accrued Expenses	19.62	14.23	9.68	5.12	1.89
Current Portion of Long-Term Debt	-	-	-	8.97	2.94
Current Portion of Leases	0.91	0.19	0.22	0.19	0.07
Other Current Liabilities	0.54	0.44	1.12	0.17	0.07
Total Current Liabilities	30.53	21.37	14.25	15.43	5.98
Long-Term Debt	3	-	-	6.53	12.06
Long-Term Leases	3.33	0.05	0.24	0.26	0.05
Other Long-Term Liabilities	3.8	-	0.01	0.35	0.35
Total Liabilities	42.27	21.42	14.51	22.57	18.44
Common Stock	0.01	0.01	-	-	0
Additional Paid-In Capital	1,025	951.35	6.84	3.64	3.27
Retained Earnings	-337.67	-217.98	-129.94	-81.34	-45.89
Total Common Equity	687.64	733.38	-123.1	-77.69	-42.62
Shareholders' Equity	687.64	733.38	184.79	125.18	40.25
Total Liabilities & Equity	729.91	754.8	199.3	147.75	58.69
Total Debt	7.24	0.24	0.46	15.94	15.13
Net Cash (Debt)	673.02	741.76	187.21	127.54	38.48
Net Cash Growth	24.54%	296.21%	46.79%	231.45%	-
Net Cash Per Share	9.03	11.87	43.23	34.09	10.54
Filing Date Shares Outstanding	80.67	76.22	66.64	3.84	3.65
Total Common Shares Outstanding	78.28	76.15	5.22	3.84	3.65
Working Capital	665.26	732.84	179.87	131.78	52.43
Book Value Per Share	8.78	9.63	-23.57	-20.22	-11.67
Tangible Book Value	673.17	733.38	-123.1	-77.69	-42.62
Tangible Book Value Per Share	8.60	9.63	-23.57	-20.22	-11.67

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q